Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Moodys
Colorcon
Medtronic
Merck
Farmers Insurance
QuintilesIMS
Dow
US Department of Justice

Generated: February 17, 2019

DrugPatentWatch Database Preview

Drug Price Trends for LAMIVUDINE

« Back to Dashboard

Drug Price Trends for LAMIVUDINE

Average Pharmacy Cost for LAMIVUDINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LAMIVUDINE-ZIDOVUDINE TABLET 76282-0115-60 1.22440 EACH 2019-01-23
LAMIVUDINE 150 MG TABLET 00904-6583-04 1.02007 EACH 2019-01-23
LAMIVUDINE 150 MG TABLET 50268-0459-11 1.02007 EACH 2019-01-23
LAMIVUDINE 150 MG TABLET 31722-0753-60 1.02007 EACH 2019-01-23
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for LAMIVUDINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
LAMIVUDINE 150MG TAB Major Pharmaceuticals 00904-6583-04 3X10 155.93 2018-12-01 - 2023-11-30 FSS
LAMIVUDINE 150MG TAB Golden State Medical Supply, Inc. 60429-0353-60 60 261.51 4.35850 EACH 2018-01-01 - 2022-12-31 FSS
LAMIVUDINE 300MG TAB Golden State Medical Supply, Inc. 60429-0354-30 30 261.51 8.71700 EACH 2018-01-01 - 2022-12-31 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Teva
Harvard Business School
Moodys
Citi
Boehringer Ingelheim
US Army
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.